These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25418464)

  • 1. Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.
    Ly KH; Régent A; Molina E; Saada S; Sindou P; Le-Jeunne C; Brézin A; Witko-Sarsat V; Labrousse F; Robert PY; Bertin P; Bourges JL; Fauchais AL; Vidal E; Mouthon L; Jauberteau MO
    Arthritis Res Ther; 2014 Nov; 16(6):487. PubMed ID: 25418464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.
    Planas-Rigol E; Terrades-Garcia N; Corbera-Bellalta M; Lozano E; Alba MA; Segarra M; Espígol-Frigolé G; Prieto-González S; Hernández-Rodríguez J; Preciado S; Lavilla R; Cid MC
    Ann Rheum Dis; 2017 Sep; 76(9):1624-1634. PubMed ID: 28606962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis.
    Dimitrijevic I; Malmsjö M; Andersson C; Rissler P; Edvinsson L
    Ophthalmology; 2009 May; 116(5):990-6. PubMed ID: 19410957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.
    Dimitrijevic I; Andersson C; Rissler P; Edvinsson L
    Ophthalmology; 2010 Mar; 117(3):628-36. PubMed ID: 20036012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.
    Lozano E; Segarra M; Corbera-Bellalta M; García-Martínez A; Espígol-Frigolé G; Plà-Campo A; Hernández-Rodríguez J; Cid MC
    Ann Rheum Dis; 2010 Feb; 69(2):434-42. PubMed ID: 19289383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptors in giant cell arteritis. An immunocytochemical, western blot and RT-PCR study.
    Petursdottir V; Nordborg E; Moraghebi N; Persson M; Nordborg C
    Clin Exp Rheumatol; 1999; 17(6):671-7. PubMed ID: 10609065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNAs and their target gene networks implicated in arterial wall remodelling in giant cell arteritis.
    Bolha L; Pižem J; Frank-Bertoncelj M; Hočevar A; Tomšič M; Jurčić V
    Rheumatology (Oxford); 2020 Nov; 59(11):3540-3552. PubMed ID: 32594153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical analysis of fibroblasts in giant cell arteritis.
    Parreau S; Vedrenne N; Regent A; Richard L; Sindou P; Mouthon L; Fauchais AL; Jauberteau MO; Ly KH
    Ann Diagn Pathol; 2021 Jun; 52():151728. PubMed ID: 33798926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
    Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC
    Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling.
    Rodríguez-Pla A; Bosch-Gil JA; Rosselló-Urgell J; Huguet-Redecilla P; Stone JH; Vilardell-Tarres M
    Circulation; 2005 Jul; 112(2):264-9. PubMed ID: 15998676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis.
    Croci S; Zerbini A; Boiardi L; Muratore F; Bisagni A; Nicoli D; Farnetti E; Pazzola G; Cimino L; Moramarco A; Cavazza A; Casali B; Parmeggiani M; Salvarani C
    Ann Rheum Dis; 2016 Aug; 75(8):1527-33. PubMed ID: 26342092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis.
    Lozano E; Segarra M; García-Martínez A; Hernández-Rodríguez J; Cid MC
    Ann Rheum Dis; 2008 Nov; 67(11):1581-8. PubMed ID: 17584806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial.
    Klink T; Geiger J; Both M; Ness T; Heinzelmann S; Reinhard M; Holl-Ulrich K; Duwendag D; Vaith P; Bley TA
    Radiology; 2014 Dec; 273(3):844-52. PubMed ID: 25102371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
    Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
    Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.
    Baldini M; Maugeri N; Ramirez GA; Giacomassi C; Castiglioni A; Prieto-González S; Corbera-Bellalta M; Di Comite G; Papa I; Dell'antonio G; Ammirati E; Cuccovillo I; Vecchio V; Mantovani A; Rovere-Querini P; Sabbadini MG; Cid MC; Manfredi AA
    Arthritis Rheum; 2012 Mar; 64(3):854-65. PubMed ID: 21989653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis.
    Kaiser M; Weyand CM; Björnsson J; Goronzy JJ
    Arthritis Rheum; 1998 Apr; 41(4):623-33. PubMed ID: 9550471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.
    Corbera-Bellalta M; García-Martínez A; Lozano E; Planas-Rigol E; Tavera-Bahillo I; Alba MA; Prieto-González S; Butjosa M; Espígol-Frigolé G; Hernández-Rodríguez J; Fernández PL; Roux-Lombard P; Dayer JM; Rahman MU; Cid MC
    Ann Rheum Dis; 2014 Mar; 73(3):616-23. PubMed ID: 23625984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in temporal arteries: comparative analysis between patients with biopsy-positive giant cell arteritis, biopsy-negative giant cell arteritis and biopsy-negative without arteritis.
    Grossman C; Yassin N; Avivi C; Bornstein G; Ben-Zvi I; Barshack I
    Clin Exp Rheumatol; 2019; 37 Suppl 117(2):122-129. PubMed ID: 31162032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.
    Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Grau JM; Urbano-Márquez A; Colomer D; Kleinman HK; Cid MC
    Circulation; 2003 May; 107(19):2428-34. PubMed ID: 12742994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation.
    Régent A; Ly KH; Groh M; Khifer C; Lofek S; Clary G; Chafey P; Baud V; Broussard C; Federici C; Labrousse F; Mesturoux L; Le Jeunne C; Vidal E; Brezin A; Witko-Sarsat V; Guillevin L; Mouthon L
    Autoimmun Rev; 2017 Apr; 16(4):398-406. PubMed ID: 28232168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.